Literature DB >> 14079593

FLUORINATED PYRIMIDINES. XIX. SOME BIOLOGICAL EFFECTS OF 5-TRIFLUOROMETHYLURACIL AND 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE ON ESCHERICHIA COLI AND BACTERIOPHAGE T4B.

H GOTTSCHLING, C HEIDELBERGER.   

Abstract

Entities:  

Keywords:  ANTIMETABOLITES; CARBON ISOTOPES; CHROMATOGRAPHY; COLIPHAGES; ESCHERICHIA COLI; EXPERIMENTAL LAB STUDY; FLUORODEOXYURIDINE; FLUOROURACIL; METABOLISM; MUTATION; PHARMACOLOGY; PYRIMIDINES; THYMINE; VIRUS CULTIVATION

Mesh：

Substances：

Year:  1963        PMID： 14079593     DOI： 10.1016/s0022-2836(63)80101-1

Source DB:  PubMed          Journal:  J Mol Biol        ISSN： 0022-2836            Impact factor:   5.469


× No keyword cloud information.
  9 in total

1.  Effects of 5-fluoro-2'-deoxyuridine on bacterial growth. Its use for DNA labelling.

Authors:  T Reuvers; D García-Pineda; C A Dávila
Journal:  Antonie Van Leeuwenhoek       Date:  1973       Impact factor: 2.271

2.  Inhibition of mouse LM cell replication by trifluorothymidine: role of cytosolic deoxythymidine kinase.

Authors:  B L Wigdahl; J R Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

3.  TAS-102 in metastatic colorectal cancer (mCRC): efficacy, tolerability, and quality of life in heavily pretreated elderly patients: a real-life study.

Authors:  Giuseppe Cicero; Raffaele Addeo; Rossella De Luca; Giuseppe Lo Re; Leonardo Gulotta; Pierenrico Marchesa; Gaspare Gulotta
Journal:  Drugs Context       Date:  2020-09-18

4.  New active drugs for the treatment of advanced colorectal cancer.

Authors:  Alberto Zaniboni
Journal:  World J Gastrointest Surg       Date:  2015-12-27

Review 5.  Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

6.  Activity of trifluorothymidine against cytomegalovirus.

Authors:  J R Wingard; R K Stuart; R Saral; W H Burns
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

7.  Corneal epithelial dysplasia after trifluridine use.

Authors:  P C Maudgal; B Van Damme; L Missotten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

8.  Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts.

Authors:  Norihiko Suzuki; Fumio Nakagawa; Kazuaki Matsuoka; Teiji Takechi
Journal:  Oncol Rep       Date:  2016-10-27       Impact factor: 3.906

9.  Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer.

Authors:  Norihiko Suzuki; Fumio Nakagawa; Teiji Takechi
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.